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Biomaterials generally induce a natural inflammatory response which can be altered by 
adding molecules to influence immune cell recruitment. Sphingosine-1-phosphatase (S1P) is a 
biological signaling lipid which performs the function of immunity regulation and controls the 
transportation of immune cells through the blood and body tissues. There are five S1P receptors 
(S1PRs), in which case are all G-protein coupled receptors that attach to and mediate most of the 
functions that the S1P performs. FTY720 is an agonist of 4 out of the 5 S1PRs and is known as 
immunomodulatory compound due to its ability to control the trafficking of immune cells. 
Biomaterial loaded with FTY720 were implanted into the injury skin of mice. Flow cytometry 
was used to analyze T-cell population in the digested tissues. This study shows that the 
application of FTY720, reduces inflammatory CD8+ T-cells by using a localized presentation of 
S1P which also shows how S1P signaling affects the distribution of harmful and helpful T-cells 
after injury. For the successful application of S1P in a localized tissue, it is important to consider 
the possible effects of its interaction with the environment. In an injury, with high levels of 
CD8+ T cells have been shown to block healing by increasing inflammatory cytokines (Reinke et 
al., 2013). In our study showed that local FTY720 reduces inflammatory CD8+ T-cells that helps 







Sphingosine-1-phosphatase (S1P) is a lipid signaling molecule, which regulates immune 
cell trafficking, and is derived from sphingolipid of the cell membrane (Maceyka, 2012).  S1P 
signals through receptors to regulate immunity and the transportation of cells through the blood 
and body tissues. There are five separate S1P receptors, which are all G-protein coupled, and 
mediate most of the functions that S1P has to offer (Awojoodu et al., 2013). FTY720 is 
an agonist of four out of the five S1P receptors and known as an immunomodulatory compound 
for its ability to control immune cell trafficking. According to our previous research, the 
localized application of FTY720 in an inflammatory wound stimulates S1P receptors to promote 
selective recruitment of monocytes to the tissue, promoting healing of wounds and vascular 
remodeling (Awojoodu et al., 2013 & Ogle et al., 2017). S1P receptors are also expressed on T-
cells and are critical for their trafficking between blood and tissues (Garris, 2014). T cells play 
many beneficial and harmful functions in tissue healing and therefore this study seeks to 
investigate how implantation of a biomaterial releasing FTY720 be able alter the T-cells 
population and identify the role of different types of T-cells within tissue injury contexts.  
Biomaterial PLGA Nanofibers 
Biomaterials generally induce a natural inflammatory response which can be altered by 
adding molecules to influence immune cell recruitment (Ogle et al., 2016). Poly (lactic-co-
glycolic) acid (PLGA) has attracted much attention as a base material for many biomedical 
applications, due to its clinical acceptance by the FDA. This is mostly due to its biocompatibility 
and suitability for export including to countries whose culture is not synonymous with animal-
derived products (Ogle et al., 2016). Its biodegradation rate can be tailored by changing the 
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molecular weight and copolymer ratios. Immunomodulatory drugs in PLGA materials can alter 
the immune response to the material and the injury to assist in better healing (Ogle et al., 2016). 
In this study, we included FTY720 into PLGA nanofibers to test the adaptive immune response 
to this material during injury. To understand how FTY720 alters local T-cell responses an 
understanding of different T-cell types and their functions in inflammation and regeneration is 
necessary. 
Types of T-Cells 
 The release of FTY720 from PLGA materials creates a gradient of the molecule with in 
the injured tissue. Local drug delivery can change the inflammatory cells that respond to injury, 
without causing systemic changes. T-cells consist of several types which all play different roles 
during regeneration and response to biomaterials. These types of T-cells include gamma-delta T-
cells, CD8+, CD4+, Th17 T-cells, as well as Regulatory T-cells (Treg). Gamma-delta T-cells 
have the role of up-regulating positive co-stimulatory ligands that further produce pro-
inflammatory cytokines to activate both innate and adaptive immune cells (Liu, 2010). CD8+ 
cells are the “cytotoxic” T cell sublineage that participates in innate immunity defense against 
intracellular pathogens. Furthermore, CD4+ “helper” T-cells play a role in antigen-specific, 
cognate immunity. CD4+ cells also carry out multiple purposes that range from activation of the 
cells of the innate immune system to nonimmune cells as it plays a critical mission in the 
immune suppression reaction. Tregs are a subpopulation of CD4 T-cells that assist in the 
prevention of other immune cells from attacking tissues of the same body as well as other 
harmful foreign materials in the environment. CD4+, CD8+, and Th17 T-cells have the function 
of recognizing peptide antigens. They primarily coordinate and promote several activities of 
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different inflammatory cells. In the context of regulation, an increase in Tregs or a decrease in 
CD8+ T-cells would be desirable to enhance healing and reduce total inflammation. 
Regulatory T-cells (Treg) 
Treg cells are classifiable into two broad classes: natural and adaptive commonly known 
as induced Treg. The natural Treg cells are characterized as CD4+ CD25+ T-cells that develop 
and emigrate from the thymus to assist in performing their primary role in immune homeostasis 
(Tao, 2013). The adaptive class of Treg cells includes CD4+ T-cells that acquires CD25 (IL-2R 
alpha) expression away from the thymus (Tao, 2013). The recruitment of Tregs assist in self-
renewal and the ability of the body to produce all types of cells made in the body’s tissues. The 
depletion of Tregs during the process of repair and regeneration prolongs the pro-inflammatory 
infiltrate and repair of impaired muscle (Burzyn, 2013).  The initial step of differentiation of the 
active cells during the healing process remains to be the stimulation of antigen which occurs 
because of the interaction of CD4 as a co-receptor with antigen major histocompatibility II 
(MHC II) complex (Artyomov, 2010). 
Cytotoxic T-cell (CD8+ T-cell) 
CD8+ T-cells play an important role as a body defense mechanism against intracellular 
pathogens such as the bacteria and virus. Moreover, these cells act as a surveillance for tumor, 
and help in controlling or killing the cancer cells. (Germain, 2012). These cells produce and 
release the cytotoxic granules which contain the proteins granzyme and perforin. The perforin 
attaches on the target cell membrane and forms a pore. The pore allows the granzymes to enter 
into the affected cell and this helps in shutting down the cell from producing the viral proteins. 
FTY720 has been shown to reduce the recruitment of CD8+ T-cells to peripheral injuries, 
supporting the potential to treat ongoing T-cell-medicated immunopathologic disease 
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(Pinschewer, 2000). One study shows that fracture healing is inversely correlated to the level of 
the terminally differentiated CD8+ T cell in peripheral blood, suggesting that CD8+ T-cells 
block healing (Reinke et al., 2013). 
 
The development of different biomaterials to recruit endogenous pro-regenerative cells 
assist in the generation of tissues while decreasing reliance on exogenous tissues and organ 
transplantation (Rooney, 2014). Implantation of FTY720 releasing biomaterials in an injury area 
to recruit pro-regenerative immune cell macrophage and monocytes to repair the injury tissue; 
however the effect on T-cells is unknown (Olingy, 2017). This study explored the change in T- 
cell populations after injury and biomaterial implantation. We hypothesized that local 







 The dorsal skin fold window chamber model was used as inflammatory injury model as 
previously described (Awojoodu, 2013). Mice (C57B/6) were obtained from Charles River 
Laboratories, and they were of ages 6-8 weeks. The mice were anesthetized with inhaled 
isoflurane for surgery and randomly divided into three groups: no implant, blank PLGA/PCL 
(polycaprolactone) nanofiber (NF) implants and FTY720 NF implant. Biomaterials were 
implanted into the injured skin within a titanium frame mounted on the top side of skinfold. Mice 
were euthanized by the use of CO2 asphyxiation after 24 hours. Skin was harvested and digested 
into single cells with collagenase A1. Cells were then prepared for analysis by flow cytometry. 
T-Cells enumeration by flow cytometry 
 The obtained cells from the injured skin tissue were washed in phosphate-buffered saline 
(PBS) and spun down to remove supernatant fluid. Conjugated primary antibody was added into 
each sample in 3% fetal bovine serum (FBS) in PBS. Cells were incubated in room temperature 
for 30 minutes in dark environment. After incubation, each sample was washed and resuspended 
in PBS. The following conjugated primary antibodies were used: PE/Cy7-conjugated anti CD3+, 
BV605-conjugated anti-CD4+, BV800-conjugated anti-CD8+ and PE/FITC-conjugated anti-
CD25+Foxp3+. Cells were analyzed by flow cytometry. CD3+ were staining for all T-cell 
population, CD3+CD4+ were staining for CD4 “helper” T-cells, CD3+CD8+ were staining for 
CD8 “cytotoxic” T-cells and CD3+CD4+CD25+Foxp3+were staining for Treg cells. Flow 
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cytometry allowed for phenotyping of T cells as well as their quantification so that the immune 
status of the injured skin tissue on the mice could be easily monitored. 
Statistical Analysis 
 The cell frequency from flow cytometry was analyzed by one-way ANOVA and Tukey’s 
Post hoc tests which made comparison in no implant, blank implant and FTY720 NF implant 






Implantation of FTY720 NF showed no significant recruitment of CD3+T-cells 
Recruitment of T-cells with various implants were measured with flow cytometry. The 
blank or unloaded PLGA biomaterial implanted into the wound on the mice caused the highest 
T-cells recruited to wound as compared to the no implant state, however this was not statistically 
significant (Figure 1). On adding a biomaterial with FTY720 to the wounded mice; T-cells 
inflammation showed a trend of decrease as compared to the blank biomaterial. (Figure 1)  
 
Figure 1. Implantation of FTY720 NF showed no significant recruitment of CD3+T-cells. Injuried 
mice were treated with no implant, blank biomaterial or biomaterial loaded with FTY720. Digested 
tissues were test by flow cytometry.  No significant difference by One-way ANOVA statistical analysis. 
 
CD4+ T-cells showed no significant change by various implant 
To investigate the recruitment of CD4+ T-cell population on FTY720 loaded NF, we 
performed a surgical injury model in vivo, and analyzed digested tissues with flow cytometry 
after 24 hours. No statistically significant differences were observed in CD4+ T-cells, but 
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FTY720 and no implant had a lower mean as compared to blank NF(Figure 2). The repeating 
examination is needed for further discussion. 
 
Figure 2. CD4+ T-cells showed no significant change by various implant. Wounded mice were treated 
in three groups, no implant, blank biomaterial or biomaterial loaded with FTY720. Digested tissues were 
test by flow cytometry. No significant difference by One-way ANOVA statistical analysis. 
 
Implantation of FTY720 releasing biomaterial does not significantly increase Treg Cells 
  
Figure 3. Implantation of FTY720 releasing biomaterials does not significantly increase Treg Cells. 
Wounded mice were treated with no implant, blank biomaterial or biomaterial loaded with FTY720. 





Few Tregs were present in the injured tissue and no significant changes were found 
between group. (Figure 3) Longer time points should be examined. 
Cytotoxic CD8+ T-cells are reduced by FTY720 Implants 
   
Figure 4. Cytotoxic CD8+ T-cells are reduced by FTY720 Implants. Wounded mice were treated with 
no implant, blank biomaterial or biomaterial loaded with FTY720. CD8+ T-cells were recruited 
significantly more with blank biomaterial compare to no implant and FTY720 loaded biomaterial. One-
way ANOVA and Tukey’s multiple comparison post hoc test were used in statistical analysis. 
 
CD8+ T-cells, which can negatively impact healing, (Reinke, 2013) were recruited with 
blank NF(Figure 4). Treatment with FTY720 significnatly decreased CD8+ T-cells. There has a 
growing evidence that the endogenous regeneration processes are contributed by the adaptive 
immunity. For example, previous work shows the level of the terminally differentiated CD8+T 
cell in peripheral blood is directly correlated to the delayed fracture healing (Reinke et al., 2013). 
This is very important as it opens opportunity strategies for the early and the targeted 









In this study, we have shown that CD8+ cytotoxic cells are increased in biomaterial 
induced inflammation in the dorsal skinfold window chamber injury model. The addition of 
FTY720 to the PLGA nanofibers reduces CD8+ T-cells; however, there were no changes in 
CD4+ T-cells or Tregs.  
CD8+ T-cells are a powerful group of immune cells and are important for fighting 
infectious disease; however, uncontrolled CD8+ cells can impair regeneration. CD8+ T-cells 
play an important role in the destruction of intercellular infections in addition to control of many 
other diseases. CD8+ T-cells have a particularly destructive capability which can be harnessed to 
help in cancer eradication (Ding et al. 2017). However, the cells have adverse effects on the 
human body for them contribute to rejection of organ transplant, for example, hepatic transplant 
(Mazzola et al. 2015). Also, CD8+ T-cells have an inhibitory effect on wound healing in terms of 
collagen deposition and wound breaking strength (Chen, 2014). Furthermore, the CD8+ T-cells 
causes a massive reduction in essential body cells, especially once used in fighting diseases. 
During injury, high levels of CD8+ T-cells have been shown to block healing by increasing 
inflammatory cytokines such as interferon-gamma (IFN) (Reinke et al., 2013). Here we have 
shown that local FTY720 reduces inflammatory CD8+ T-cells that helps the early anti-
inflammation healing environment. 
FTY720 is a sphingolipid analog that signals through S1P receptors. S1P signals via five 
G protein-coupled receptors, termed S1P1–5. Each of the receptors couples to several G proteins 
eliciting different downstream events including migration of the immune cells. Figure 5 shows 
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the biological functions of S1P receptor signaling. Previously, our lab have shown that FTY720 
stimulates the S1P receptors to signal selective recruitment of anti-inflammatory monocytes to 
the tissue (Awojoodu, et al., 2013). This recruitment initiates healing of wounds and vascular 
remodeling (Awojoodu, et al., 2013). S1P receptors are also expressed on T-cells and are critical 
for their trafficking between blood and tissues (Garris, 2014). FTY720 has a multi-targeted mode 
of action, and its CD8+ T-cell suppressive effects are initiated by its phosphorylation to an S1P 
analog (FTY720-P) that causes S1P receptor 1 internalization that sequesters T-cells in the 
lymph node (Ntranos, 2014). FTY720 phosphate activates all S1P receptors except S1P2. S1P 
and FTY720 phosphate are generated by intracellular phosphorylation of sphingosine and 
FTY270, respectively and transported outwards to elicit signaling via S1P receptors. 
Characteristically, FTY720 phosphate leads to agonist-induced receptor internalization of the 
S1P1 receptor. Our lab has shown that local FTY720 is found in the blood in low levels within 
the first day of material implantation (Ogle et al. 2014) and therefore may cause CD8+ cell 
activity in the blood.   
However, this study was made at early timepoints, at later timepoints FTY720 could have 
more significant effects on T-cell populations regeneration. FTY720 did not show changes on 












CONCLUSION AND FUTURE WORK 
 
 The presence of CD8+ cytotoxic cells around the blank biomaterial indicates increased 
inflammation, while FTY720 reduced CD8+ T-cells. This result support the hypothesis, FTY720 
can alter T-cell population. Application of FTY720 with biomaterials in an inflammatory wound 
can active the S1P receptors signaling which recruit the immune cells to the tissues necessary 
promote vascular remodeling. FTY720 released within the injury creates a highly localized 
vascular repair environment (Ogle et al., 2016). As the understanding of the role of the immune 
system in repair continues to grow, the opportunities also arise to solve the problems of 
engineering the strategies for regeneration of utilizing immune regenerate. As a drug delivery 
system, biomaterials have been more preferred due to its advantage in coordinating the immune 
response system. Moreover, the temporal control of drug delivery is very critical especially in 
repair and it also targets the specific phase in inflammation. Our biomaterial composition could 
be changed to alter the release kinetics. 
 In the future studies, we will look at the CD8+ T-cell negatively effective on regeneration 
and repeat this study with more timepoints to investigate if FTY720 be able to alter T-cell 
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